Jubilant Life Sciences
Jubilant Life Sciences, a prominent player in the pharmaceutical and life sciences sector, is headquartered in Noida, India. Founded in 1978, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in contract manufacturing, active pharmaceutical ingredients (APIs), and drug delivery solutions, Jubilant Life Sciences is recognised for its commitment to quality and innovation. The company’s core offerings, which include a diverse range of generic pharmaceuticals and specialty chemicals, set it apart in a competitive market. With a focus on sustainability and advanced technology, Jubilant Life Sciences has achieved significant milestones, including multiple regulatory approvals and partnerships with leading global firms. This positions the company as a trusted partner in the healthcare industry, dedicated to improving patient outcomes worldwide.
DitchCarbon Score
How does Jubilant Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jubilant Life Sciences's score of 36 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jubilant Life Sciences's reported carbon emissions
In 2023, Jubilant Life Sciences reported total carbon emissions of approximately 662,296,000 kg CO2e across all scopes. This includes about 8,492,000 kg CO2e from Scope 1, 54,703,000 kg CO2e from Scope 2, and a significant 662,296,000 kg CO2e from Scope 3 emissions. The company has shown a commitment to reducing its carbon footprint, particularly in Scope 1 and 2 emissions, which totalled approximately 63,195,000 kg CO2e in 2023. Over the years, Jubilant Life Sciences has made notable progress in emissions reduction. For instance, in 2020, the combined Scope 1 and 2 emissions were about 115,040,000 kg CO2e, which decreased to approximately 63,195,000 kg CO2e by 2023. This reflects a significant reduction in emissions intensity, demonstrating the company's efforts towards sustainability. Despite the lack of specific reduction targets or initiatives disclosed, the company continues to monitor and report its emissions, indicating a commitment to transparency and accountability in its climate strategy. As the industry faces increasing pressure to address climate change, Jubilant Life Sciences is positioned to adapt and respond to these challenges while striving for a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 894,456,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 107,906,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 12,057,000 | - | - | - | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jubilant Life Sciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
